国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Spinal cord involvement of Churg-Strauss syndrome with multi-organ disorders

第一作者:Chenlong Yang

通讯作者:Yulun XU

基本信息

  • 负责人:Chenlong Yang
  • 数据来源: OTHERS
  • 论文编号:OTHERS20190286
  • 发表时间:2014-06-01

2014-06-01

已发表文章

发表杂志:Neurol India

发表类型: Letters To Editor

影响因子(IF): 2.117

PMID: 25033859 Pubmed原文链接 全文下载

主要研究背景及目的

方法

Based on the American College of Rheumatology diagnostic criteria, a diagnosis of presumed CSS was considered. Biopsy of skin, superficial peroneal nerve, and muscle revealed vascular intimal thickening and perivascular eosinophil infiltrates.

结论

Multi‑organ involvements were reported as risk factors for adverse clinical outcomes.Thus, early diagnosis based on systematic assessment and timely treatment should be particularly emphasized in order to preventfurther progression and even life‑threatening organ involvement.

主要结果

In patients with multi‑organ involvement,1000 mg intravenous methylprednisolone for 3 days, followed by 40-60 mg of prednisone daily can induce remission.Some authors advocate the use of both corticosteroid and immunosuppressors. Prognosis of CSS is generally satisfactory, and most patients respond well to corticosteroids alone.[1,5] About 20% patients experience remissions and relapses, and in such patients, continued treatment with low‑dose glucocorticoids and close observation are needed.